The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents, and companies. The market sizes for liquid biopsy diagnostics are given for 2017, 2018 and 2023 (forecasted).
This report reviews liquid biopsy biomarkers and technologies and provides background on why liquid biopsy is increasingly viewed as a replacement for, or a companion to, tissue biopsy. The report then discusses several of the significant large-scale research initiatives that are contributing to liquid biopsy development. Key forces driving the market are enumerated.
The structures of several important industry subsectors are reviewed, as well as major industry acquisitions and strategic alliances from January 2017 through November 2018. Industry subsectors analyzed include advanced sequencing instruments; droplet digital PCR (polymerase chain reaction); target enrichment; single-cell DNA polymerase; non-invasive prenatal testing (NIPT); fetal-cell NIPT; CTC (circulating tumor cell) capture and detection; and liquid biopsy.
The market for liquid biopsy diagnostics is analyzed in depth. The market is analyzed by application (cancer, reproductive health, transplant), biomarker type (nucleic acids, cells, extracellular vesicles, proteins), analysis platform (microarray, NGS, PCR, proteomics, and other), analysis purpose (screening/early detection, diagnosis, therapy guidance, monitoring), and geography (North America, Europe, Asia/Pacific, Rest of World).
Market data covers 2017, 2018 and 2023 (forecasted).
More than 175 companies in the liquid biopsy industry are profiled in this report.
The publisher provides a summary of the main industry acquisitions and strategic alliances from January 2017 through November 2018, including key alliance trends.
The report includes:
32 data tables and 54 additional tables
Industry analysis of the liquid biopsy biomarkers and technologies market
Analyses of global market trends with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
Characterization and quantification of market potential for liquid biopsy diagnostics by application, biomarker type, analysis platform, analysis purpose, and geographical region
Discussion of several significant large-scale research initiatives that are contributing to liquid biopsy market development
Examination of various conventional biopsy methods and highlight how liquid biopsy enabling technologies address the issues and are gaining significant traction with key opinion leaders
Coverage of significant patents and their allotments in each category, as well as major industry acquisitions and strategic alliances data
Company profiles of major manufacturers and suppliers of liquid biopsy research tools, services, and diagnostics, including Agilent Technologies Inc., Cygnus Biosciences, Illumina Inc., Oxford Nanopore, Qiagen, Quantum Biosystems, Roche and Thermo Fisher Scientific
Key Topics Covered
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Chapter 2 Summary
Chapter 3 Overview
Introduction
Report Scope
Liquid Biopsy Versus Traditional Biopsy
Markets
Forces Driving Growth
Key Trends
Industry
Chapter 4 Technology Background
Liquid Biopsy Biomarkers
Cancer Genomics
Non-Invasive Prenatal Testing
Circulating Tumor Cell Technologies
CTC Workflow
Cell Isolation Technologies
CTC Sample Preparation Technologies
CTC Downstream Analysis Technologies
Comparison of Liquid Biopsy with Conventional Biopsy
Cancer Testing
Prenatal Testing
Chapter 5 Liquid Biopsy Initiatives
Blood Profiling Atlas
Cancer-ID
CTC Trap Consortium
Early Cancer Detection Consortium
EpiFemCare
Human Cell Atlas
Immunomonitor Consortium
Integration of Imaging and Fluid-based Tumor Monitoring in Cancer Therapy Program
Liquid Biopsies and Imaging for Improved Cancer Care
Next-Generation Single-Cell Analysis Program
Population Sequencing Projects
Precancer Atlas
Precision Medicine Initiative
Single-Cell Proteomics and Lipidomics Project
TopMed
Worldwide Innovative Networking (WIN) Consortium
Single-Cell Research
Cambridge Single-Cell Analysis Core Facility
Harvard Medical School Single-Cell Core
Mayo Medical Genome Facility
National Center for Single-Cell Biology
Single-Cell Analysis Core
UC San Francisco Single-Cell Analysis Center
Chapter 6 Market Breakdown by End User
Introduction
Cancer Applications
Precision Medicine
Cancer Biomarker Status
Cancer Market Segments
Reproductive Health Applications
Transplant Diagnostics Applications
Chapter 7 Liquid Biopsy Industry
Advanced Sequencing Instruments Industry
Droplet Digital PCR Industry
Target Enrichment and Amplification Industry
Single-Cell DNA Polymerase Industry
Non-Invasive Prenatal Testing Industry
Fetal Cell NIPT Industry
CTC Capture and Detection Industry
Liquid Biopsy Assay Industry
Chapter 8 Industry Acquisitions and Strategic Alliances
Acquisitions
Strategic Alliances
Key Trends
2017 Alliances
2018 Alliances
Chapter 9 Liquid Biopsy Markets
Forces Driving Growth
Liquid Biopsy Market by Indication
Liquid Biopsy Market by Biomarker Type
Liquid Biopsy Market by Analysis Platform
Liquid Biopsy Market by Analysis Purpose
Non-Invasive Prenatal Testing Market
Cancer Markets
Cancer Market by Indication
Cancer Market by Analysis Purpose
Cancer Market by Biomarker Class
Cancer Market by Analysis Method
Breast Cancer Market
Colorectal Cancer Market
Hematological Cancer Market
Lung Cancer Market
Pan-cancer Market
Transplant Markets
Regional Market Analysis
Chapter 10 Patent Review/ New Developments
Circulating Tumor Cell Patents
Exosome Patents
Cell-free DNA Patents
Liquid Biopsy and Sequencing-related Patent Issues
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, In Vitro Diagnostics
Related Links:
Author: Copyright GlobeNewswire, Inc. 2016. All rights reserved. You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.
